What is the ticker symbol for Corcept Therapeutics Incorporated?

The ticker symbol for Corcept Therapeutics Incorporated is NASDAQ:CORT

Does Corcept Therapeutics Incorporated pay dividends?

No, Corcept Therapeutics Incorporated does not pay dividends

What sector is Corcept Therapeutics Incorporated in?

Corcept Therapeutics Incorporated is in the Healthcare sector

What industry is Corcept Therapeutics Incorporated in?

Corcept Therapeutics Incorporated is in the Biotechnology industry

What country is Corcept Therapeutics Incorporated based in?

Corcept Therapeutics Incorporated is headquartered in United States

When did Corcept Therapeutics Incorporated go public?

Corcept Therapeutics Incorporated initial public offering (IPO) was on April 14, 2004

Is Corcept Therapeutics Incorporated in the S&P 500?

No, Corcept Therapeutics Incorporated is not included in the S&P 500 index

Is Corcept Therapeutics Incorporated in the NASDAQ 100?

No, Corcept Therapeutics Incorporated is not included in the NASDAQ 100 index

Is Corcept Therapeutics Incorporated in the Dow Jones?

No, Corcept Therapeutics Incorporated is not included in the Dow Jones index

When was Corcept Therapeutics Incorporated last earnings report?

Corcept Therapeutics Incorporated's most recent earnings report was on July 29, 2026

When does Corcept Therapeutics Incorporated report earnings?

The next expected earnings date for Corcept Therapeutics Incorporated is November 4, 2026

CORT Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, CORT price is $114.47, up +3.58% on August 14, 2026
Current Price All-Time High: CORT price is currently -6.33% below its historical high of $122.21 set on July 30, 2026
Market Cap: CORT current market cap is $12B, up +63.23% over the past 365 days
PE Ratio: CORT current PE ratio is 273.39
Revenue: CORT current annual revenue is $761.41M, up +12.79% year-over-year
Next Earnings: The next earnings release for CORT is on November 4, 2026

Profile

Company profile for Corcept Therapeutics Incorporated (CORT)
Metric	Value
Full Name	Corcept Therapeutics Incorporated
Ticker	NASDAQ: CORT
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Apr 14, 2004
Indexes	Not included
Website	corcept.com
Employees	500

Key Metrics

Corcept Therapeutics Incorporated Key Details
Metric	Value	Date
Price	$114.47	Aug 14, 26
Price, 1D Change	+3.58%	Aug 14, 26
Market Cap	$12B	Aug 14, 26
	-	Aug 14, 26
PE Ratio	273.39	Aug 14, 26
Beta	1.84	Aug 14, 26
Revenue	$761.41M	Dec 31, 25
Revenue, 1Y Change	+12.79%	Dec 31, 25
EPS	$0.82	Dec 31, 25
EPS, 1Y Change	-33.55%	Dec 31, 25

Events

Corcept Therapeutics Incorporated Events
Metric	Value	Date
Next Earnings		Nov 4, 26
Last Qtr. Earnings		Jul 29, 26
Last Ann. Earnings		Feb 24, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

CORT Estimates
Metric	Value	Date
EPS	$0.82	Dec 31, 25
EPS Estimate	$2.13	N/A
EPS Est. Change	+160.73%	N/A
Revenue	$761.41M	Dec 31, 25
Revenue Estimate	$1.15B	N/A
Revenue Est. Change	+50.63%	N/A
Current Price	$114.47	Aug 14, 26
Price Target	$163.00	-
Price Tgt. Change	+42.40%	-

🔒 Log In To Unlock Full Data

EPS

CORT EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$1.41	$1.23	-12.47%
2025	$0.96	$0.82	-14.41%
2026	$2.13	N/A	+160.73%
2027	$4.52	N/A	+452.03%

Revenue

CORT revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$693.23M	$675.04M	-2.62%
2025	$814.21M	$761.41M	-6.48%
2026	$1.15B	N/A	+50.63%
2027	$1.76B	N/A	+131.40%

🔒 Log In To Unlock Full Data

Performance

CORT Performance
Metric	Value	Date
Price, 1Y	+58.99%	Aug 14, 26
Price, 3Y	+268.43%	Aug 14, 26
Market Cap, 1Y	+63.23%	Aug 14, 26
Market Cap, 3Y	+288.50%	Aug 14, 26
Revenue, 1Y	+12.79%	Dec 31, 25
Revenue, 3Y	+89.47%	Dec 31, 25
EPS, 1Y	-33.55%	Dec 31, 25
EPS, 3Y	-6.32%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

CORT Technical Indicators
Metric	Value	Date
Current Price	$114.47	Aug 14, 26
SMA 200	$63.62	Aug 14, 26
SMA 50	$92.88	Aug 14, 26
EMA 200	$70.58	Aug 14, 26
EMA 50	$93.10	Aug 14, 26
MACD	$6.55	Aug 14, 26
Beta	1.84	Aug 14, 26
ATR	$4.86	Aug 14, 26
14-Day RSI	64.77	Aug 14, 26
10-Day Volatility	38.16%	Aug 14, 26

Dividends

CORT Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Aug 14, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

CORT Income & Profitability
Metric	Value	Date
Revenue	$761.41M	Dec 31, 25
EPS	$0.82	Dec 31, 25
Gross Profit	$748.43M	Dec 31, 25
Gross Margin	98.30%	Dec 31, 25
Operating Income	$44.80M	Dec 31, 25
Operating Margin	5.88%	Dec 31, 25
Net Income	$98.17M	Dec 31, 25
Net Margin	12.89%	Dec 31, 25
EBITDA	$46.69M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

CORT Financial Health
Metric	Value	Date
Debt To Equity	0.01	Dec 31, 25
	2.89	Dec 31, 25
	2.82	Dec 31, 25
	-	Dec 31, 25
	6	Jun 30, 26
	41.64	Aug 14, 26

Valuations

CORT Valuations
Metric	Value	Date
PE Ratio	273.39	Aug 14, 26
	14.89	Aug 14, 26
	17.53	Aug 14, 26
	1,368.30	Aug 14, 26
	-	N/A

Balance Sheet

CORT Balance Sheet
Metric	Value	Date
Book Value	$647.81M	Dec 31, 25
	$372.15M	Dec 31, 25
	$838.03M	Dec 31, 25
	$480.40M	Dec 31, 25
	$190.23M	Dec 31, 25
	$166.09M	Dec 31, 25
Total Debt	$6.11M	Dec 31, 25
	$1.08M	Dec 31, 25
	$40.44M	Dec 31, 25

Expenses

CORT Expenses
Metric	Value	Date
	$663.24M	Dec 31, 25
	$703.63M	Dec 31, 25
	$12.98M	Dec 31, 25
	$0.00	Dec 31, 25
	$1.89M	Dec 31, 25
	$0.00	Dec 31, 25
	-$33.19M	Dec 31, 25

Cash Flow

CORT Cash Flow
Metric	Value	Date
	$142.00M	Dec 31, 25
	$69.76M	Dec 31, 25
	-$220.37M	Dec 31, 25
Capex	$211.00K	Dec 31, 25
	$141.79M	Dec 31, 25

Recent analyst updates

CORT Recent analyst updates
Metric	Value	Date
Piper Sandler	→	Jul 30, 26
HC Wainwright & Co.	→	Jul 30, 26
Canaccord Genuity	→	Jul 30, 26
Canaccord Genuity	→	Jul 29, 26
Wolfe Research	→	Jul 27, 26
HC Wainwright & Co.	→	May 28, 26
Canaccord Genuity	→	May 28, 26
UBS	→	May 13, 26
HC Wainwright & Co.	→	May 4, 26
Piper Sandler	→	May 1, 26

Analyst sentiment

Institutional ownership

Screeners with CORT

FAQ

What is the ticker symbol for Corcept Therapeutics Incorporated?: The ticker symbol for Corcept Therapeutics Incorporated is NASDAQ:CORT
Does Corcept Therapeutics Incorporated pay dividends?: No, Corcept Therapeutics Incorporated does not pay dividends
What sector is Corcept Therapeutics Incorporated in?: Corcept Therapeutics Incorporated is in the Healthcare sector
What industry is Corcept Therapeutics Incorporated in?: Corcept Therapeutics Incorporated is in the Biotechnology industry
What country is Corcept Therapeutics Incorporated based in?: Corcept Therapeutics Incorporated is headquartered in United States
When did Corcept Therapeutics Incorporated go public?: Corcept Therapeutics Incorporated initial public offering (IPO) was on April 14, 2004
Is Corcept Therapeutics Incorporated in the S&P 500?: No, Corcept Therapeutics Incorporated is not included in the S&P 500 index
Is Corcept Therapeutics Incorporated in the NASDAQ 100?: No, Corcept Therapeutics Incorporated is not included in the NASDAQ 100 index
Is Corcept Therapeutics Incorporated in the Dow Jones?: No, Corcept Therapeutics Incorporated is not included in the Dow Jones index
When was Corcept Therapeutics Incorporated last earnings report?: Corcept Therapeutics Incorporated's most recent earnings report was on July 29, 2026
When does Corcept Therapeutics Incorporated report earnings?: The next expected earnings date for Corcept Therapeutics Incorporated is November 4, 2026

Data Sources & References

CORT Official Website www.corcept.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1088856/000162828026011091/0001628280-26-011091-index.htm
CORT Profile on Yahoo Finance finance.yahoo.com/quote/CORT
CORT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cort